Serum levels of neuron-specific enolase in children with diabetic ketoacidosis

Journal of Child Neurology

Volumn 32, Issue 5, 2017, Pages 475-481

  Hamed, Sherifa ^a   Metwalley, Kotb Abbass ^b   Farghaly, Hekma Saad ^b   Sherief, Tahra ^a  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

Brain injury; Diabetic ketoacidosis; Neuron specific enolase

Indexed keywords

BICARBONATE; GLUCOSE; NEURON SPECIFIC ENOLASE; NITROGEN; SODIUM; UREA; BIOLOGICAL MARKER; ENOLASE;

ADOLESCENT; AGE; ARTICLE; CASE CONTROL STUDY; CHILD; CROSS-SECTIONAL STUDY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM INJURY; PATIENT ATTITUDE; PH; PRIORITY JOURNAL; SERUM OSMOLARITY; BLOOD; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; MALE; PHOSPHOPYRUVATE HYDRATASE; SEVERITY OF ILLNESS INDEX;

EID: 85015914308     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073816686718     Document Type: Article

References (52)

1. Daneman D. Type 1 diabetes. Lancet. 2006;367:847-858.
2. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10(suppl 12):3-12.
3. Dabelea D, Bell RA, D'Agostino RB, et al. Writing group for the SEARCHfor diabetes in youth study group. Incidence of diabetes in youth in the United States. J AmMed Assoc. 2007;297:2716-2724.
4. International Diabetes Federation. The IDF Diabetes Atlas. 5th ed. Brussels: International Diabetes Federation; 2011. http://www.idf.org/idf-diabetes-atlas-fifth-edition. Accessed April 23. 2013. 1
5. United States Census Bureau. International Database. Washington, DC: US Census Bureau; 2013. http://www.census.gov/popu lation/international/data/idb/informationGateway.php. Accessed April 23, 2013.
6. Patterson C, Guariguata L, Dahlquist G, et al. Diabetes in the young-a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract. 2014; 103:161-175.
7. El-Ziny MA, Salem NA, El-Hawary AK, et al. Epidemiology of childhood type 1 diabetes mellitus in Nile Delta, northern Egypt-a retrospective study. J Clin Res Pediatr Endocrinol. 2014;6:9-15.
8. Pinkey JH, Bingley PJ, Sawtell PA, et al. Presentation and progress of childhood diabetes mellitus: A prospective populationbased study. The Bart's-Oxford Study Group. Diabetologia. 1994;37:70-74.
9. Basu A, Close CF, Jenkins D, et al. Persisting mortality in diabetic ketoacidosis. Diabet Med. 1993;10:282-284.
10. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001;85:16-22.
11. Samahy MH, Elbarbary NS, Elmorsi HM. Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt. Where do we stand now? And where do we go from here? Diabetes Res Clin Pract. 2015;107:370-376.
12. Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: The SEARCH for diabetes in youth study. Pediatrics. 2014;133:e938-e945.
13. Wootton-Gorges SL, Buonocore MH, Caltagirone RA, et al. Progressive decrease in N-acetylaspartate/creatine ratio in a teenager with type 1 diabetes and repeated episodes of ketoacidosis without clinically apparent cerebral edema: evidence for permanent brain injury. AJNR Am J Neuroradiol. 2010;31: 780-781.
14. Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344:264-269.
15. Ghetti S, Lee JK, Sims CE, et al. Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr. 2010; 156:109-114.
16. Nadebaum C, Scratch SE, Northam EA, Cameron FJ; Diabetic Ketoacidosis and Brain Injury Study Group. Clinical utility of mental state screening as a predictor of intellectual outcomes 6 months after diagnosis of type 1 diabetes. Pediatr Diabetes. 2012; 13:632-637.
17. Cato MA, Mauras N, Mazaika P, et al; Diabetes Research in Children Network. Longitudinal evaluation of cognitive functioning in young children with type 1 diabetes over 18 months. J Int Neuropsychol Soc. 2016;22:293-302.
18. Aye T, Reiss AL, Kesler S, et al. The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care. 2011;34:1458-1462.
19. Pell GS, Lin A, Wellard RM, et al. Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes. Diabetes Care. 2012;35:513-519.
20. Cameron FJ, Scratch SE, Nadebaum C, et al. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care. 2014;37:1554-1562.
21. Glaser N, Ngo C, Anderson S, et al. Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism. Diabetes. 2012;61:1831-1837.
22. Toprak H, Yetis H, Alkan A, et al. Relationships of DTI findings with neurocognitive dysfunction in children with type 1 diabetes mellitus. Br J Radiol. 2016;89:20150680.
23. Lo W, O'Donnell M, Tancredi D, et al. Diabetic ketoacidosis in juvenile rats is associated with reactive gliosis and activation of microglia in the hippocampus. Pediatr Diabetes. 2016;17:127-139.
24. RoeTF, Crawford TO,HuffKR, et al.Brain infarction in childrenwith diabetic ketoacidosis. J Diabetes Complications. 1996;10:100-108.
25. Siqueira LF. Cerebrovascular complications of diabetic ketoacidosis in children. Arq Bras Endocrinol Metabol. 2011;55:288-290.
26. Skogseid IM, Nordby HK, Urdal P, et al. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir (Wien). 1992;115:106-111.
27. Guzel A, Er U, Tatli M, et al. Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury. Neurosurg Rev. 2008;31: 439-444.
28. Hamed SA, Eltayeb AA, Mohamad HO, Moussa EM. Brain function in children with uncomplicated epilepsy: relationship to biomarkers of brain damage (neuron specific enolase and S100b protein). J Pediatr Epilepsy. 2013;2:115-124.
29. Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci. 2003;21:177-190.
30. Chiang JL, Kirkman MS, Laffel LM, et al. Type 1 diabetes through the life span: A position statement of the American Diabetes Association. Diabetes Care. 2014;37:2034-2054.
31. Rewers A, Klingensmith G, Davis C, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: The Search for Diabetes in Youth Study. Pediatrics. 2008;121:e1258-e1266.
32. Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev. 1990;11: 297-304.
33. Shaklai S, Peretz R, Spasser R, et al. Long-term functional outcome after moderate-to-severe paediatric traumatic brain injury. Brain Inj. 2014;28:915-921.
34. Wolfsdorf J, Craig ME, Daneman D, et al. Diabetic ketoacidosis. Pediatr Diabetes. 2007;8:28-43.
35. Paus E, Nustad K. Immunoradiometric assay for alpha gammaand gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin Chem. 1989;35:2034-2038.
36. Kitabchi AE, Wall BM.Management of diabetic ketoacidosis. Am Fam Physician. 1999;60:455-464.
37. Bui TP, Werther GA, Cameron FJ. Trends in diabetic ketoacidosis in childhood and adolescence: A 15-yr experience. Pediatr Diabetes. 2002;3:82-88.
38. Shera AS, Miyan Z, Basit A, et al. Trends of type 1 diabetes in Karachi, Pakistan. Pediatr Diabetes. 2008;9(4 pt 2):401-406.
39. Sandhu HS, Butt AN, Powrie J, Swaminathan R. Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus. Ann N Y Acad Sci. 2008;1137:258-263.
40. Hamed SA, Abd Elaal RF, Mohamad KA, et al. Neuropsychological, neurophysiological and laboratory markers of direct brain injury in type 2 diabetes mellitus. J Neurol Neurosci. 2012;3.
41. Li J, Yan M, Zhang Y, et al. Serum neuron-specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema. Diabet Med. 2015;32:102-107.
42. Glaser N, Bundros A, Anderson S, et al. Brain cell swelling during hypocapnia increases with hyperglycemia or ketosis. Pediatr Diabetes. 2014;15:484-493.
43. Kim HB, Jang MH, Shin MC, et al. Treadmill exercise increases cell proliferation in dentate gyrus of rats with streptozotocininduced diabetes. J Diabetes Complications. 2003;17:29-33.
44. Nett ST, Noble JA, Levin DL, et al. Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot study. J Pediatr Intensive Care. 2014;3.
45. Lee DM, Hoffman WH, Carl GF, et al. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J Diabetes Complications. 2002;16:294-300.
46. Dalton RR, Hoffman WH, Passmore GG, Martin SL. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann Clin Lab Sci. 2003;33:435-442.
47. Hoffman WH, Burek CL, Waller JL, et al. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003;108: 175-181.
48. Ding D, Moskowitz SI, Li R, et al. Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol. 2000; 162:1-12.
49. Ryan CM,Williams TM. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J Clin Exp Neuropsychol. 1993;15:685-700.
50. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care. 2005;28: 71-77.
51. Hamed SA. Diabetes mellitus and the brain: special emphasis to cognitive function. Int J Diabetol Vasc Dis Res. 2013;1:803.
52. Cheng F, Yuan Q, Yang J, et al. The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis. PLoS One. 2014;9:e106680.